Brisbane, CA, United States of America

Yan Poon

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Unity Biotechnology, Inc.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Poon. Retrieved from https://idiyas.com/inventor/yan-poon-i74d2n8c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Brisbane, CA (US) (2020 - 2021)
  • South San Francisco, CA (US) (2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Ophthalmology by Yan Poon

Introduction

Yan Poon is an accomplished inventor based in Brisbane, CA (US). He has made significant contributions to the field of ophthalmology, particularly in developing methods to address age-related eye conditions. With a total of 3 patents, his work focuses on innovative solutions that target the underlying causes of these conditions.

Latest Patents

One of Yan Poon's latest patents is centered on methods of inhibiting pathological angiogenesis. This invention is based on the discovery that many eye conditions associated with aging are mediated at least in part by cells bearing a senescent phenotype. Senescent cells accumulate with age and express factors that contribute to the pathophysiology of age-related conditions. The data show that in age-matched patients, the severity of age-related conditions correlates with the abundance of senescent cells. Clearing senescent cells can help abrogate the condition. Small molecule drugs that remove senescent cells from affected tissue in the eye are provided, which have special efficacy in treating ophthalmic conditions. These drugs not only inhibit the progression of the disease but can also reverse some of the pathophysiology—such as neovascularization and vaso-obliteration—that lead to vision loss. These senolytic agents have an appropriate dose and specificity profile to be effective in the clinical management of previously intractable ophthalmic conditions.

Career Highlights

Yan Poon is currently associated with Unity Biotechnology, Inc., where he continues to innovate in the field of age-related diseases. His work has garnered attention for its potential to transform the treatment landscape for patients suffering from debilitating eye conditions.

Collaborations

Some of his notable coworkers include Pam Tsuruda and Jill Hopkins, who contribute to the collaborative environment at Unity Biotechnology, Inc. Their combined expertise enhances the research and development efforts within the company.

Conclusion

Yan Poon's innovative work in ophthalmology exemplifies the impact of targeted research on age-related conditions. His patents reflect a commitment to improving patient outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…